Articles
Daily market commentary and analysis.
Novo Nordisk Just Declared a Price War on Weight-Loss Drugs
Novo Nordisk just dropped a bomb on the GLP-1 market. The Danish pharma giant announced Tuesday that it will slash the U.S. list prices of Wegovy, Ozempic, and Rybelsus to a flat $675 per month…
Feb 24, 2026
AI Panic? More Like AI Opportunity (If You Don't Lose Your Cool)
So here’s what happened yesterday: Someone at Citrini Research basically yelled “FIRE!” in a crowded theater, except the theater was the stock market and the fire was… artificial intelligence taking…
Feb 24, 2026
When Smart Money Gets Dumb: Why This Top Economist Thinks We're All About to Get Schooled
You know that feeling when everyone at the party is having way too much fun, and you’re the only one wondering who’s going to clean up the mess? That’s basically where top economist Mark Zandi finds…
Feb 24, 2026
The Government Just Broke Its Own Rules (And Your Portfolio Should Care)
Remember when building anything in America required navigating more red tape than a Christmas present? Well, plot twist: the government just decided those rules don’t apply anymore. At least not if…
Feb 24, 2026
That Awkward Moment When a Top Economist Says the Market is Living in Fantasy Land
So here’s the thing about economists – they’re usually about as exciting as watching paint dry on a rainy Tuesday. But when Mark Zandi from Moody’s Analytics starts waving red flags about the stock…
Feb 24, 2026
Royal Caribbean Insiders Just Dumped $166 Million — Here's What They See
When one insider sells, it’s a tax bill. When the entire C-suite sells at the same time, it’s a warning flare. Over the past two weeks, Royal Caribbean’s executive team has unloaded a staggering $166…
Feb 23, 2026
Domino's Just Proved the American Consumer Isn't Dead Yet
In a market getting pummeled by tariff anxiety and tech selloffs, Domino’s Pizza did something radical on Monday: it went up. Shares surged 6% after the pizza giant dropped a Q4 earnings report that…
Feb 23, 2026
Gilead Drops $7.8 Billion on a Cancer Drug That Hasn't Been Approved Yet
Just days after CEO Daniel O’Day told investors M&A wasn’t an urgent priority, Gilead Sciences dropped $7.8 billion to gobble up Arcellx — the biotech partner it’s been courting since 2022. The…
Feb 23, 2026
The Government Just Broke Its Own Rules (And Your Portfolio Should Care)
Remember when building anything in America took longer than a Marvel movie franchise? Well, plot twist: the government just hit the fast-forward button, but only for their favorite kids. While…
Feb 23, 2026
AI Just Broke the Job Market (And Your Portfolio Might Be Next)
Remember when your biggest career worry was whether robots would steal factory jobs? Well, plot twist: they’re coming for the corner office instead. We’re witnessing what economists are calling “The…
Feb 23, 2026
Nvidia Insiders and Billionaires Are Selling Before Wednesday's Earnings
When the people who know a company best are selling, it’s worth paying attention. Three Nvidia executives have dumped over $105 million in stock since January 1st, and four billionaire fund managers…
Feb 23, 2026
Novo Nordisk Just Lost the Weight-Loss Drug War's Biggest Battle
Novo Nordisk had one job: prove its next-generation obesity drug could go toe-to-toe with Eli Lilly’s juggernaut. It couldn’t. Results from the Redefine 4 trial, released Monday morning, showed that…
Feb 23, 2026
Investors Are Quietly Abandoning US Stocks at the Fastest Pace in 16 Years
The biggest rotation in 16 years is happening and most retail investors are sleeping through it. U.S.-domiciled investors have yanked $75 billion from American equity products in the last six months…
Feb 23, 2026
The S&P 500 Just Hit 6,000 Again (And Why That's Actually a Big Deal)
Well, well, well. Look who decided to show up to the 6,000 party again. The S&P 500 just closed at exactly 6,000 on Friday, and honestly, it feels like watching your friend finally get their life…
Feb 23, 2026
Your Designer Bag Just Beat Your Stock Portfolio (And It's Not Even Close)
Remember when your friend dropped $36,000 on a tiny Hermès bag and you thought they’d lost their mind? Plot twist: they might be the smartest investor you know. While you’ve been stress-watching your…
Feb 23, 2026
Your Hermès Bag Just Beat Your Stock Portfolio (And It's Not Even Close)
Remember when your friend dropped $36,000 on a tiny Hermès bag and you thought they’d lost their mind? Well, plot twist: they might be the smartest investor you know. While you’ve been obsessing over…
Feb 23, 2026
Your Portfolio Wishes It Was a Purse: How Hermès Bags Are Schooling the S&P 500
While you’ve been obsessing over whether to buy more NVIDIA or finally diversify into something boring like bonds, there’s been a quiet revolution happening in the world of luxury accessories. And…
Feb 22, 2026
A US Strike on Iran Could Send Oil Past $100 — Markets Aren't Ready
The Strait of Hormuz. Three words that should be on every trader’s watchlist this week. President Trump signaled Thursday that he’ll decide within ten days whether to launch strikes against Iran. The…
Feb 22, 2026
Gold Hit $5,000 and Mining Stocks Are Still Cheap — Here's Why
There’s a paradox unfolding in precious metals that should have every value investor paying attention. Gold has shattered $5,000 per ounce. Silver blew through $100 and is trading near $110. Yet the…
Feb 22, 2026
Grail's Cancer Blood Test Just Failed Its Biggest Trial — Stock Cut in Half
Grail just learned what happens when the most anticipated clinical trial in cancer diagnostics misses its mark. The stock lost nearly half its value on Friday. The company’s Galleri blood test —…
Feb 22, 2026